Compare SMG & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMG | IDYA |
|---|---|---|
| Founded | 1868 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | N/A | 2019 |
| Metric | SMG | IDYA |
|---|---|---|
| Price | $67.32 | $32.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $70.83 | $49.67 |
| AVG Volume (30 Days) | ★ 938.2K | 844.7K |
| Earning Date | 01-28-2026 | 02-13-2026 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $3,400,900,000.00 | $214,834,000.00 |
| Revenue This Year | N/A | $2,688.43 |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | $44.30 | ★ N/A |
| Revenue Growth | N/A | ★ 5377.66 |
| 52 Week Low | $45.61 | $13.45 |
| 52 Week High | $70.67 | $39.28 |
| Indicator | SMG | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 67.59 | 42.28 |
| Support Level | $61.93 | $31.81 |
| Resistance Level | $66.00 | $33.63 |
| Average True Range (ATR) | 2.26 | 1.48 |
| MACD | 0.19 | -0.21 |
| Stochastic Oscillator | 90.51 | 16.95 |
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.